Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis

Tetard, C; Mittaine, M; Bui, S; Beaufils, F; Maumus, P; Fayon, M; Burgel, PR; Lamireau, T; Delhaes, L; Mas, E; Enaud, R

Enaud, R (corresponding author), Hop Enfants, CHU Bordeaux, CRCM Pediat, Pl Amelie Raba Leon, F-33076 Bordeaux, France.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020; 71 (6): 778

Abstract

A chronic intestinal inflammation may occur in patients with cystic fibrosis (CF), while no therapeutic management is proposed. Although Lumacaftor/Iv......

Full Text Link